71%(7)5 out of 7 people found this document helpful
This preview shows page 3 - 5 out of 6 pages.
Understand and apply key terms, concepts, and principles related to prescribing drugs to treat hematologic disordersPhoto Credit: N/A – Laureate ImageLearning ResourcesThis page contains the Learning Resources for this week. Be sure to scroll down the page to see all of this week's assigned Learning Resources. To access select media resources, please use the media player below.Required ReadingsArcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (Eds.). (2017). Pharmacotherapeutics for advanced practice: A practical approach(4th ed.). Ambler, PA: Lippincott Williams & Wilkins.Review Chapter 50, “Pharmacotherapy for Venous Thromboembolism Prevention and Treatment, Stroke Prevention in Atrial Fibrillation, and Thromboembolism Prevention with Mechanical Heart Valves” (pp. 863-886)This chapter covers drug therapy options for three disorders requiring anticoagulants: venous thromboembolism, atrial fibrillation, and ischemic stroke. It also explains the process of initiating and managing drug therapy for patients with these disorders.Chapter 51, “Anemias” (pp. 891-906) This chapter examines causes of various types of anemia and associated cell alterations. It also explores types of drugs used for treatment and patient factors to consider when initiating drug therapy.Drugs.com. (2012). Retrieved from This website presents a comprehensive review of prescription and over-the-counter drugs including information on common uses and potential side
effects. It also provides updates relating to new drugs on the market, supportfrom health professionals, and a drug-drug interactions checker.Optional ResourcesRefer to the Optional Resources listed in Week 1.Discussion: Pharmacotherapy forHematologic DisordersIn the 1970s, the average lifespan for patients diagnosed with sickle cell disease was 14 years. Today, the average lifespan has increased to 50 years and beyond (TriHealth, 2012). The patient prognosis for many other